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Thedelta-sarcoglycan-deﬁcienthamsterisanexcellentmodeltostudymusculardystrophy.Gaitdisturbances,importantclinically,
have not been described in this animal model. We applied ventral plane videography (DigiGait) to analyze gait in BIO TO-2
dystrophic and BIO F1B control hamsters walking on a transparent treadmill belt. Stride length was ∼13% shorter (P<. 05) in
TO-2 hamsters at 9 months of age compared to F1B hamsters. Hindlimb propulsion duration, an indicator of muscle strength,
was shorter in 9-month-old TO-2 (247 ± 8ms) compared to F1B hamsters (272 ± 11ms; P<. 05). Braking duration, reﬂecting
generation of ground reaction forces, was delayed in 9-month-old TO-2 (147 ± 6ms) compared to F1B hamsters (126 ± 8ms;
P<. 05). Hindpaw eversion, evidence of muscle weakness, was greater in 9-month-old TO-2 than in F1B hamsters (17.7 ± 1.2
◦
versus 8.7 ± 1.6
◦; P<. 05). Incline and decline walking aggravated gait disturbances in TO-2 hamsters at 3 months of age. Several
gait deﬁcits were apparent in TO-2 hamsters at 1 month of age. Quantitative gait analysis demonstrates that dystrophic TO-2
hamstersrecapitulatefunctionalaspectsofhumanmusculardystrophy.Earlydetectionofgaitabnormalitiesinaconvenientanimal
model may accelerate the development of therapies for muscular dystrophy.
1.Introduction
Muscular dystrophy includes loss of muscle strength and
muscle mass and leads to gait disturbances resulting in
compensatory kinematic and postural adaptation [1–3].
Eventually, patients lose their ability to stand upright and
walk. Clinical gait analysis of subjects with muscular dystro-
phy is widely used to test the eﬃcacy of new drugs because
there are few reliable methods to determine function in
muscular dystrophy [1]. Histopathological studies of animal
models, including the delta-sarcoglycan-deﬁcient dystrophic
hamster,haveplayedanimportantroleinourunderstanding
and treatment of muscular dystrophy [4]. Functional phe-
notypic evidence, however, of restoration of muscle strength
with therapy in animal models, is becoming increasingly
important in preclinical drug development [5–9]. A recent
study of canine muscular dystrophy accounted for the slower
walking speed in dystrophic subjects to more accurately
quantifythekinematicsofpathologicgaitduringoverground
walking [10]. Treadmill gait analysis provides the oppor-
tunity to have all subjects walk at the same speed to rule
out diﬀerences in walking speed as being the most impor-
tant confounder in the interpretation of gait disturbances.
Treadmill gait analysis has recently been applied to the
characterization of mouse models of amyotrophic lateral
sclerosis [11, 12], rat models of nerve injury [13, 14], and
canine arthritis [15]. Quantitative kinematic gait analysis in
a small animal model of muscular dystrophy, however, has
not yet been reported. We, therefore, performed treadmill
gait analysis in the BIO TO-2 strain of myopathic hamsters
to fully characterize their posture and kinematics during
walking. The BIO TO-2 [TO-2] hamster, with a deletion
in the delta-sarcoglycan gene, is a widely studied animal
model of muscular dystrophy [16–20]. These animals show
pathological signs of muscular dystrophy, including elevated
serum creatine kinase and central nucleation and necrosis of
muscle ﬁbers. We compared gait in the myopathic hamsters
to the gait in healthy BIO F1B [F1B] control hamsters2 Journal of Biomedicine and Biotechnology
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Figure 1: (a) Lateral view of a 9-month-old TO-2 dystrophic hamster walking on DigiGait transparent treadmill belt. The animal walks
within an adjustable polycarbonate housing to accommodate a range of animal sizes walking or running at a range of walking speeds (0 to
100cm/s). (b) Individual color image (top) from a digital video recording of the underside of a walking hamster, representing one instance
in time. A digital mask was placed over the snout, based on the symmetry and direction of the animal, to prevent the snout from being
misinterpreted as a paw. (Bottom) DigiGait software subtracts from each image the pixels that do not match the color of the paws and
converts the images to binary, resulting in digital paw prints of the walking hamster. (c) Representative dynamic gait signals of the left
forelimb and right hindlimb of a hamster walking at a speed of 16cm/s. Durations of stance, swing, and stride are indicated for the right
hindlimb. Durations of propulsion and braking are indicated for the left forelimb.
and found several functional indices that signiﬁcantly and
consistently deviate beginning early in life. The method
described in this report provides quantitative functional
metrics of gait associated with sarcoglycan deﬁciency in a
readily available animal model.
2. Methods
2.1. Animals. Male BIO F1B control and BIO TO-2 dys-
trophic hamsters were obtained from Bio Breeders, Inc.,
Fitchburg, MA. Handling and care of hamsters were con-
sistent with federal guidelines and approved institutional
protocols.
2.2. Gait Dynamics. Gait dynamics were recorded using
ventral plane videography, as previously described [21, 22].
Brieﬂy, we devised a motor-driven treadmill with a trans-
parent treadmill belt [DigiGait Imaging System, Mouse
Speciﬁcs, Inc., Quincy, MA]. A high-speed digital video
camera was positioned below the transparent belt to focus
on the ventral view of subjects walking atop of the belt.
An acrylic compartment, ∼7cmwideby∼30cm long and
adjustable for length and width, was mounted on top of
the treadmill to maintain the hamsters within the view
of the camera. Figure 1(a) depicts a 9-month-old TO-2
hamster walking on the treadmill belt within the acrylic
compartment. Digital video images of the underside of
hamsters were recorded at ∼125 frames per second. Each
image represents ∼8ms; the paw area indicates the temporal
placement of the paw relative to the treadmill belt. The
color images (Figure 1(b), top panel) were converted to
their binary matrix equivalents (Figure 1(b), bottom panel)
and the areas of the approaching or retreating paws rel-
ative to the belt and camera were calculated throughout
each stride. The plotted area of each digital paw print
(paw contact area) imaged sequentially in time provides a
dynamic gait signal, representing the temporal record of paw
placement relative to the treadmill belt (Figure 1(c)). Each
gait signal for each limb comprises a stride duration which
includes the stance duration when the paw of a limb is in
contact with the walking surface, plus the swing duration
when the paw of the same limb is not in contact withJournal of Biomedicine and Biotechnology 3
Table 1: Gait dynamics in 9-month-old F1B control hamsters and
delta-sarcoglycan-deﬁcient TO-2 dystrophic hamsters walking on a
treadmill belt at a speed of 16cm/s.
Gait index F1B (n = 9) TO-2 (n = 14)
Stride length (cm) 8.0 ±0.27 .1 ±0.1
∗
Stride frequency (Hz) 2.0 ±0.12 .3 ±0.1
∗
Stride duration (ms) 503 ±7 443 ±4∗
% Stance 72.4 ±0.57 4 .8 ±0.4
∗
% Swing 27.6 ±0.52 5 .2 ±0.4
∗
Forelimb stance width 2.4 ±0.12 .1 ±0.1
∗
Forelimb stride length CV (%) 17.6 ±1.62 3 .6 ±1.4
∗
Hindlimb stance width (cm) 3.8 ±0.13 .9 ±0.1
Hindlimb paw placement angle (◦)8 .7 ±1.61 7 .7 ±1.2
∗
Data are means ± SE; ∗P<. 05, compared to F1B control hamsters.
the walking surface. Stance duration was further subdivided
into braking duration (increasing paw contact area over
time) and propulsion duration (decreasing paw contact area
over time) (Figure 1(c)).
Stride frequency was calculated from the number of gait
signals over time. Stride length was calculated from the
following equation: speed = stride frequency × stride length.
Stance widths and paw placement angles at full stance were
obtained by ﬁtting ellipses to the paws and determining the
centers, vertices, and major axes of the ellipses. Forelimb and
hindlimb stance widths were calculated as the perpendicular
distance between the major axis of the left and right fore
paw images and between the major axis of the left and right
hindpaw images during peak stance. Paw placement angle
was calculated as the angle that the long axis of a paw makes
with the direction of motion of the animal during peak
stance. Gait data were collected and pooled from both the
left and right forelimbs, and the left and right hindlimbs.
Measures of stride-to-stride variability (gait variability)
for stride length and stance width were determined as the
standard deviation and the coeﬃcient of variation (CV). The
standard deviation reﬂects the dispersion about the average
v a l u ef o rap a r a m e t e r .C V ,e x p r e s s e da sa% ,w a sc a l c u l a t e d
fromthefollowingequation:100 ×standarddeviation/mean
value.
Each hamster was allowed to explore the treadmill com-
partment for ∼1 minute to acclimatize it to the apparatus.
There are few data on hamsters walking on motorized
treadmills. We therefore randomly selected TO-2 and F1B
hamsters and subjected them to a range of walking speeds.
We selected 16cm/s for the 3-month- and 9-month-old
hamsters since most animals walked comfortably at this
speedanditwassuﬃcientlyfasttopreventthehamstersfrom
rearing or turning around during videography. We selected
a walking speed of 25cm/s for the more active 1-month-
old hamsters. We recorded ∼3 seconds of video images for
each hamster walking at a speed of 16cm/s to provide more
than 7 sequential strides. Only video segments of hamsters
walking with a regularity index of 100% [23]w e r eu s e df o r
imageanalysis.Forinclineanddeclinewalking,thetreadmill,
walking compartment, and camera system were pitched at
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Figure 2: (a) The relative contributions of swing, braking, and
propulsion to the stride duration of forelimbs and hindlimbs in 9-
month-old F1B control hamsters walking at 16cm/sec. ∗P<. 05,
forelimbs versus hindlimbs.
an angle so that the animals walked up an incline of ∼15◦ or
down a decline of ∼15◦, dependent on the direction of the
treadmill belt. The angle of treadmill incline and decline was
based on published protocols [8, 16, 24]. The treadmill belt
was wiped clean between studies if necessary.
2.3. Statistics. Data are presented as means ± SE. ANOVA
was used to test for statistical diﬀerences among TO-2 and
F1B hamsters at each age. When the F-score exceeded Fcritical
for α = 0.05, we used post-hoc unpaired Student’s two-
tailed t-tests to compare group means. Gait indices between
forelimbs and hindlimbs within groups were compared
using paired Student’s two-tailed t-tests. Diﬀerences were
considered signiﬁcant with P<. 05.
3. Results
3.1. Gait Dynamics in Hamsters. The ventral view of a
9-month-old healthy F1B control hamster walking on a
transparent treadmill belt is shown in Video 1 (Video 1,
available as supplemental material). Gait indices for adult
F1B hamsters are summarized in Table 1.F 1 Bh a m s t e r s
(n = 9) walked ∼2 steps every second, completed one stride
within ∼500ms, and traversed ∼8cm with each step walking
at a speed of 16cm/s. The contributions of stance and swing
duration to stride duration were ∼75% (stance/stride) and
∼25% (swing/stride).
Diﬀerences in the posture and gait dynamics of the
forelimbs and hindlimbs were quantiﬁed. Forelimb stance
width was signiﬁcantly narrower than hindlimb stance width
(2.4 ± 0.1cm versus 3.8 ± 0.1cm, P<. 05). Stance width
variability (CV%) of hindlimbs was lower than that of
forelimbs in 9-month-old F1B hamsters walking at a speed
of 16cm/s. Figure 2 illustrates the relative contributions of
swing, stance, braking, and propulsion to the stride duration
of forelimbs and hindlimbs in 9-month-old F1B hamsters.
Swing duration of the forelimbs was slightly longer than of
the hindlimbs. The braking phase was greater in forelimbs
than in hindlimbs (34.3±2.1% versus 24.8±2.3%, P<. 05),
and the propulsion phase was greater in hindlimbs than in
forelimbs (75.2 ± 2.3% versus 65.6 ± 2.1%, P<. 05) with4 Journal of Biomedicine and Biotechnology
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Figure 3: (a) Gait signal of the left hindlimb of a TO-2 hamster superimposed over the gait signal of the left hindlimb of a F1B control
hamster. Stride frequency was signiﬁcantly higher and stride length signiﬁcantly shorter in TO-2 dystrophic hamsters compared to F1B
control hamsters. Propulsion duration (arrows) was signiﬁcantly shorter in TO-2 hamsters compared to F1B control hamsters. This ﬁnding
was consistent in hamsters studied at 1 month, 3 months, and 9 months of age. (b) The relative contributions of braking and propulsion to
thestancedurationofforelimbsandhindlimbsin9-month-oldF1BcontrolhamstersandTO-2delta-sarcoglycan-deﬁcienthamsterswalking
at 16cm/sec. The relative contributions of forelimb braking and propulsion to stance were signiﬁcantly altered in TO-2 dystrophic hamsters
(∗P<. 05, TO-2 versus F1B hamsters). Although propulsion duration was decreased in TO-2 hamsters, the contribution of propulsion to
stance was not diﬀerent.
comparable stance durations of forelimbs (367 ± 8ms) and
hindlimbs (361 ±8ms).
3.2. Gait in Dystrophic Hamsters. Gait dynamics were signif-
icantly diﬀerent in 9-month-old TO-2 dystrophic hamsters
(n = 14) compared to age-matched F1B control hamsters
(n = 9) (Table 1). Figure 3(a) illustrates the gait signal from
the left hindlimb of a TO-2 hamster superimposed over the
gait signal of the left hindlimb of a F1B hamster. Stride
frequency was increased in TO-2 compared to F1B hamsters.
Stride duration was signiﬁcantly shorter in TO-2 than that
in F1B hamsters (443 ± 4ms versus 503 ± 7ms;P<. 05).
This was attributable to a shorter swing duration (112 ± 2
versus 139 ± 5ms;P<. 05), and a shorter stance duration
(331±3ms versus 364±6ms;P<. 05) in TO-2 compared to
F1Bhamsters.StridelengthwasdecreasedinTO-2compared
to F1B hamsters (7.1 ± 0.1cmversus8.0 ± 0.2cm;P<. 05)
at a walking speed of 16cm/s. Forelimb stance width was
narrower in TO-2 compared to F1B hamsters (2.1 ± 0.1cm
versus 2.4 ± 0.1cm;P<. 05). The paw placement angle of
the hindlimbs was also more signiﬁcantly everted in TO-2
than in F1B hamsters (17.7±1.2
◦ versus 8.7±1.6
◦; P<. 05).Journal of Biomedicine and Biotechnology 5
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Figure 4: Three-month old TO-2 dystrophic hamsters exhibited signiﬁcant gait diﬀerences that were consistent with those observed in 9-
month-old animals. (a) Stride length was shorter and (b) stance width narrower in 3-month-old TO-2 hamsters. (c) Diﬀerences in forelimb
braking duration and (d) hindlimb propulsion duration while walking horizontally [center bars] were exacerbated with uphill walking [left
bars] and downhill walking [right bars]. #P<. 001 TO-2 compared to F1B.
Forelimb stride length variability was higher in TO-2 than in
F1B hamsters (23.6±1.4% versus 17.6±1.6%; P<. 05). The
braking duration of the forelimbs, which is the time needed
to decelerate the animal, was prolonged in TO-2 compared
to F1B hamsters (147 ± 6ms versus 126 ± 8ms;P<. 05).
The propulsion duration of the hindlimbs, which reﬂects
the interval available for force generation, was shortened in
TO-2 compared to F1B hamsters (242 ± 7ms versus 272 ±
11ms; P<. 05) (Figure 3(a), arrows). Figure 3(b) illustrates
the relative contributions of braking and propulsion to the
stance duration of forelimbs and hindlimbs in 9-month-old
F1B control hamsters and TO-2 delta-sarcoglycan-deﬁcient
hamsters walking at 16cm/sec. The relative contributions of
forelimb braking to stance were signiﬁcantly altered in TO-2
dystrophic hamsters.
3.3. Early Functional Phenotype of Muscular Dystrophy. Most
of the gait disturbances observed in 9-month-old dystrophic
hamsterswerealsoapparentat3 months ofage.Stride length
was decreased in 3-month-old TO-2 dystrophic hamsters
(n = 12) compared to F1B control hamsters (n = 6) (7.2 ±
0.1cmversus8.4 ± 0.2cm;P<. 05) at a walking speed of
16cm/s. Hindlimb stance width was narrower in TO-2 than
in F1B hamsters (3.7 ± 0.1cmversus4.0 ± 0.1cm;P<. 05).
Forelimb stance width was signiﬁcantly narrower in TO-2
than in F1B hamsters when the animals were challenged to
walk uphill or downhill (Figure 4). As in older animals, the
paw placement angle of the 3-month-old dystrophic TO-2
hindlimbs was more signiﬁcantly everted than that in F1B
controls (16.4 ± 1.2
◦ versus 12.4 ± 1.6
◦; P<. 05). Whereas
the braking duration of the forelimbs was not diﬀerent in6 Journal of Biomedicine and Biotechnology
3-month-old TO-2 from F1B hamsters walking horizontally,
the propulsion duration of the hindlimbs was shortened
in 3-month-old TO-2 hamsters (241 ± 6ms versus 298 ±
9ms; P<. 05). Challenging the animals to walk uphill
and downhill, moreover, exacerbated functional diﬀerences
between 3-month-old TO-2 (n = 4) and F1B hamsters
(n = 4) (Figure 4).
Even at 1 month of age, several gait indices deviated
signiﬁcantly in TO-2 dystrophic hamsters. Compared to 1-
month-old F1B control hamsters (n = 5), 1-month-old
TO-2 dystrophic hamsters (n = 4) were characterized by
signiﬁcantly shorter stride length (6.6 ± 0.1cmversus7.1 ±
0.1cm), more eversion of the hindpaw (22.4 ± 1.8
◦ versus
17.9±1.8
◦), shortened hindlimb propulsion duration (125±
5 m sv e r s u s1 4 8± 5ms), and prolonged forelimb braking
duration (81±3m sv e r s u s4 4±5ms)(allP<. 05). Forelimb
stride length variability tended to be higher in 1-month-
o l dT O - 2c o m p a r e dt oF 1 Bh a m s t e r s( 1 8 .1 ± 1.2% versus
15.1±1.4%; P<. 08). Figure 5 illustrates diﬀerences in stride
length between F1B control and TO-2 dystrophic hamsters
across the three ages studied.
4. Discussion
This is the ﬁrst comprehensive analysis of posture and gait in
hamsters, and the ﬁrst quantitative analysis of gait changes in
a small animal model of muscular dystrophy. Gait analysis of
patients with muscular dystrophy is implemented to assess
disease progression [1–3]. Mouse and hamster models are
widely used to better understand and develop therapies for
muscular dystrophy; yet, very little is known about how
these animals walk. The postural and kinematic gait data
we provide in F1B control hamsters and delta-sarcoglycan-
deﬁcient TO-2 dystrophic hamsters may help to establish
reference values for future studies aimed at reversing gait
abnormalities with potential therapeutics tested in this
animal model.
There are at least nine diﬀerent types of muscular
dystrophy. Loss of muscle strength is common to all types of
muscular dystrophies; age of onset, muscle groups involved,
and progression vary. Mutations in the sarcoglycan-gene
result in limb-girdle muscular dystrophy (LGMD), of which
there are diﬀerent types [25]. The limb-girdle (shoulders
and hips) muscles are usually the ﬁrst aﬀected, with muscle
weakness becoming more progressive and spreading to
more distal muscles, including tibialis anterior [26], wrists
[27], and hands [28]. Delta-sarcoglycan deﬁciency results
in LGMD-type 2F [29]. Most LGMD-type 2F patients have
severe muscular dystrophy that presents early in life and
progresses rapidly.
The TO-2 hamster, with a deletion in the delta-
sarcoglycan gene and deﬁciency of alpha-, beta-, and
gamma-sarcoglycan, has been widely studied [16–20]a n d
is considered a good animal model of human LGMD-type
2F. Gross examination upon autopsy of the parental strain
of TO-2 hamsters indicated that shoulder muscles were the
most aﬀected [30]. Pathology has also indicated damage to
the intercostal muscles, proximal limb muscles, muscles of
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Figure 5: Gait disturbances were evident in TO-2 dystrophic
hamsters at 1-month of age. Stride length, for example, was
consistently signiﬁcantly shorter in the delta-sarcoglycan-deﬁcient
dystrophichamsterscomparedtoF1Bcontrolhamstersat1-month,
3-months, and 9-months of age. ∗P<. 05, TO-2 compared to F1B.
the pelvic girdle, and muscles of the back and the abdominal
wall [17]. Gastrocnemius, triceps, and tibialis muscles have
also been shown to be aﬀected [7, 16, 20, 31]. All of these
muscles are involved in quadrupedal gait.
Despite extensive pathology evidence of muscle damage,
very little is known about muscle dysfunction in animal
models of muscular dystrophy, including the TO-2 hamster
[32]. Xiao et al. demonstrated reduced tibialis anterior
muscle strength in dystrophic hamsters [20]. Zhu et al.
reported reduced treadmill running endurance as a measure
of weakness in TO-2 hamsters [16]. Vitiello et al. concluded
that gene therapy ameliorated muscular dystrophy in ham-
sters based on their improved rotarod performance [7]. Our
treadmill gait analysis study sought to reconcile systemic
muscle weakness with the ability to walk, functionality most
important to patients with muscular dystrophy.
Observation of TO-2 hamsters in their cage does not
suggest that they have gait disturbances, which is why we
studied treadmill gait analysis in 9-month-old animals, an
age of which the animals are known to have signiﬁcant
muscle weakness. The ∼13% shorter stride length in the
dystrophic hamsters is a very robust deﬁcit; in otherwise
healthy patients with neuromuscular disease, ∼10% reduc-
tions in stride length can be clinically relevant. Because
the treadmill speed was set to 16cm/s for both TO-2
dystrophic and F1B control animals, the shorter stride length
intheTO-2animalsrequiredsigniﬁcantlyincreasedstepping
frequency. Increased stepping frequency as part of daily life
poses increased cardiorespiratory demands [33]. The paw
placement angle of the hindlimbs was more open in TO-2
animals, suggesting weakness of muscle in the hindpaws or
lower hindlimbs. Though the hindlimb propulsion duration
was shorter, the percentage of contribution of the hindlimbs
to propulsion was not diﬀerent in TO-2 from that of F1BJournal of Biomedicine and Biotechnology 7
hamsters, suggesting that the shorter propulsion duration
was secondary to a shorter stride cycle.
There were several important diﬀerences in forelimb gait
in TO-2 dystrophic compared to F1B control hamsters. This
is in contrast to some animal models of neuromuscular
diseases, such as the SOD1 G93A mouse model of amy-
otrophic lateral sclerosis, in which the gait disturbances are
more localized to the hindlimbs [11]. The forelimb stance
width was signiﬁcantly narrower; often, changes in base of
supportarecompensatorytomuscularandvestibulardefects
tomaintainpostureandbalance.Theforelimbbrakingdura-
tion was prolonged, but more signiﬁcantly, the percentage
contribution of forelimb deceleration was larger in TO-2
hamsters. Taken together, muscle weakness of the shoulder
girdle and forelimbs might contribute substantively to the
gait disturbances in TO-2 hamsters. This shoulder girdle
functional readout is notable given that the supraspinatus
musclewasthemostseverelyaﬀectedinautopsieddystrophic
hamsters [30], the relatively larger load carried by the upper
limbs in quadrupeds compared to humans, and the known
involvement of the shoulder girdle in LGMD patients.
The diﬀerences in gait between 3-month-old F1B and
TO-2 hamsters were strikingly similar to those observed in
older animals. This may not be surprising, however, since
histopathology indicates extensive muscle pathology at this
age [16, 17, 19, 31, 34]. Challenging the animals to incline or
decline walking exacerbated postural and kinematic diﬀer-
ences. Downhill walking especially increased the magnitude
of diﬀerences in stride length, stance width, and propulsion
duration. Walking up an incline or down a decline is known
to changes muscle load and force distribution [35, 36]; this
is especially true for quadrupeds that use their forelimbs
for weight support. Downhill walking has been shown
to increase loading on the shoulders and upper limbs of
pongids [37], cats [36], and rats [38]. Shoulder muscles
a r ep a r t i c u l a r l yv u l n e r a b l ei nL G M D .T h eo b s e r v a t i o n s
of exacerbated upper limb gait disturbances in the TO-2
hamsters downhill walking suggest that the shoulder girdle
m a yb em o r ea ﬀected, at least functionally, than the hip
girdle in the delta-sarcoglycan-deﬁcient hamster model of
muscular dystrophy.
Skeletal muscle pathology is already evident in TO-2
animals one month old [17, 19, 30, 34]. We observed
signiﬁcant diﬀerences in posture and gait between 1-month-
old TO-2 dystrophic and F1B control hamsters. Several
metrics, including shorter stride length and greater hindpaw
eversion, were consistent ﬁndings in juvenile (1-month-
old), young (3-month-old), and adult (9-month-old) delta-
sarcoglycan-deﬁcient dystrophic hamsters. In summary, gait
analysis in delta-sarcoglycan-deﬁcient dystrophic BIO TO-2
hamsters provides early functional evidence of systemic
muscle weakness that could accelerate the screening of
potential therapies for muscular dystrophy.
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